Met Life Investment Management, LLC Seres Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

  • $14.7 Billion
  • Q1 2024

Shares

46 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

May 09, 2024
BUY
$2.33 - $5.07 $32,205 - $70,077
13,822 Added 36.74%
51,439 $122,000
Q2 2023

Apr 29, 2024
BUY
$4.67 - $6.55 $240,220 - $336,925
51,439 New
51,439 $246,000
Q2 2023

Aug 10, 2023
BUY
$4.67 - $6.55 $64,548 - $90,534
13,822 Added 36.74%
51,439 $246,000
Q1 2023

May 09, 2024
BUY
$4.95 - $6.09 $186,204 - $229,087
37,617 New
37,617 $213 Million
Q1 2023

May 15, 2023
BUY
$4.95 - $6.09 $28,145 - $34,627
5,686 Added 17.81%
37,617 $213,000
Q4 2022

May 10, 2024
SELL
$5.09 - $9.05 $33,828 - $60,146
-6,646 Reduced 17.23%
31,931 $178,000
Q4 2022

Jun 14, 2023
SELL
$5.09 - $9.05 $28,941 - $51,458
-5,686 Reduced 15.12%
31,931 $178,000
Q4 2022

Mar 22, 2023
SELL
$5.09 - $9.05 $33,828 - $60,146
-6,646 Reduced 17.23%
31,931 $178,000
Q4 2022

Feb 15, 2023
SELL
$5.09 - $9.05 $33,828 - $60,146
-6,646 Reduced 17.23%
31,931 $178,000
Q3 2022

May 10, 2024
BUY
$3.5 - $7.2 $93,635 - $192,621
26,753 Added 226.26%
38,577 $247,000
Q3 2022

Jun 14, 2023
BUY
$3.5 - $7.2 $3,360 - $6,912
960 Added 2.55%
38,577 $247,000
Q3 2022

Mar 22, 2023
BUY
$3.5 - $7.2 $93,635 - $192,621
26,753 Added 226.26%
38,577 $247,000
Q3 2022

Nov 14, 2022
BUY
$3.5 - $7.2 $93,635 - $192,621
26,753 Added 226.26%
38,577 $248,000
Q2 2022

May 10, 2024
SELL
$2.7 - $7.62 $75,384 - $212,750
-27,920 Reduced 70.25%
11,824 $40,000
Q2 2022

Jun 20, 2023
SELL
$2.7 - $7.62 $69,641 - $196,542
-25,793 Reduced 68.57%
11,824 $40,000
Q2 2022

Mar 22, 2023
SELL
$2.7 - $7.62 $75,384 - $212,750
-27,920 Reduced 70.25%
11,824 $40,000
Q2 2022

Aug 11, 2022
SELL
$2.7 - $7.62 $75,384 - $212,750
-27,920 Reduced 70.25%
11,824 $41,000
Q1 2022

May 10, 2024
BUY
$6.3 - $8.84 $250,387 - $351,336
39,744 New
39,744 $282,000
Q1 2022

Jun 20, 2023
BUY
$6.3 - $8.84 $13,400 - $18,802
2,127 Added 5.65%
39,744 $282,000
Q1 2022

Mar 22, 2023
BUY
$6.3 - $8.84 $89,485 - $125,563
14,204 Added 55.61%
39,744 $282,000
Q1 2022

May 12, 2022
BUY
$6.3 - $8.84 $89,485 - $125,563
14,204 Added 55.61%
39,744 $283,000
Q4 2021

May 17, 2024
BUY
$6.02 - $11.43 $76,369 - $145,000
12,686 Added 98.69%
25,540 $212,000
Q4 2021

Jun 21, 2023
SELL
$6.02 - $11.43 $72,703 - $138,040
-12,077 Reduced 32.11%
25,540 $212,000
Q4 2021

Mar 22, 2023
BUY
$6.02 - $11.43 $76,369 - $145,000
12,686 Added 98.69%
25,540 $212,000
Q4 2021

Feb 15, 2022
BUY
$6.02 - $11.43 $76,369 - $145,000
12,686 Added 98.69%
25,540 $213,000
Q3 2021

May 17, 2024
SELL
$5.46 - $22.6 $68,872 - $285,076
-12,614 Reduced 49.53%
12,854 $89,000
Q3 2021

Jun 21, 2023
SELL
$5.46 - $22.6 $135,205 - $559,643
-24,763 Reduced 65.83%
12,854 $89,000
Q3 2021

Mar 22, 2023
SELL
$5.46 - $22.6 $68,872 - $285,076
-12,614 Reduced 49.53%
12,854 $89,000
Q3 2021

Nov 15, 2021
SELL
$5.46 - $22.6 $68,872 - $285,076
-12,614 Reduced 49.53%
12,854 $89,000
Q2 2021

May 17, 2024
BUY
$18.46 - $24.36 $70,591 - $93,152
3,824 Added 17.67%
25,468 $607,000
Q2 2021

Jun 21, 2023
SELL
$18.46 - $24.36 $224,270 - $295,949
-12,149 Reduced 32.3%
25,468 $607,000
Q2 2021

Mar 22, 2023
BUY
$18.46 - $24.36 $70,591 - $93,152
3,824 Added 17.67%
25,468 $607,000
Q2 2021

Aug 16, 2021
BUY
$18.46 - $24.36 $70,591 - $93,152
3,824 Added 17.67%
25,468 $607,000
Q1 2021

May 17, 2024
BUY
$17.66 - $28.92 $382,233 - $625,944
21,644 New
21,644 $445,000
Q1 2021

Jun 26, 2023
SELL
$17.66 - $28.92 $282,083 - $461,939
-15,973 Reduced 42.46%
21,644 $446 Million
Q1 2021

Mar 22, 2023
SELL
$17.66 - $28.92 $19,991 - $32,737
-1,132 Reduced 4.97%
21,644 $445,000
Q1 2021

May 14, 2021
SELL
$17.66 - $28.92 $19,991 - $32,737
-1,132 Reduced 4.97%
21,644 $446,000
Q4 2020

Jun 22, 2023
SELL
$23.25 - $37.73 $345,053 - $559,950
-14,841 Reduced 39.45%
22,776 $558,000
Q3 2020

May 24, 2024
SELL
$3.74 - $28.74 $112 - $862
-30 Reduced 0.13%
22,776 $645 Million
Q3 2020

Jun 26, 2023
SELL
$3.74 - $28.74 $55,505 - $426,530
-14,841 Reduced 39.45%
22,776 $644,000
Q3 2020

Mar 22, 2023
SELL
$3.74 - $28.74 $112 - $862
-30 Reduced 0.13%
22,776 $644,000
Q3 2020

Nov 13, 2020
SELL
$3.74 - $28.74 $112 - $862
-30 Reduced 0.13%
22,776 $645,000
Q2 2020

May 24, 2024
BUY
$3.04 - $6.2 $69,330 - $141,397
22,806 New
22,806 $109 Million
Q2 2020

Jun 26, 2023
SELL
$3.04 - $6.2 $45,025 - $91,828
-14,811 Reduced 39.37%
22,806 $108,000
Q2 2020

Mar 22, 2023
SELL
$3.04 - $6.2 $27,740 - $56,575
-9,125 Reduced 28.58%
22,806 $108,000
Q2 2020

Aug 14, 2020
BUY
$3.04 - $6.2 $69,330 - $141,397
22,806 New
22,806 $109,000

Others Institutions Holding MCRB

# of Institutions
100
Shares Held
62.7M
Call Options Held
36.9K
Put Options Held
476K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $89.3M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email